These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
331 related articles for article (PubMed ID: 28083147)
1. Role of Eukaryotic Initiation Factors during Cellular Stress and Cancer Progression. Sharma DK; Bressler K; Patel H; Balasingam N; Thakor N J Nucleic Acids; 2016; 2016():8235121. PubMed ID: 28083147 [TBL] [Abstract][Full Text] [Related]
2. Aberration in translation initiation and associated diseases: Role of the eukaryotic translation initiation factor 3A. Zhu T; Gao Y; Li L; Wang L; Yin J; Zhou H; Zhang W; Liu Z Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Oct; 42(10):1204-1211. PubMed ID: 29093254 [TBL] [Abstract][Full Text] [Related]
3. Aberrant protein synthesis and cancer development: The role of canonical eukaryotic initiation, elongation and termination factors in tumorigenesis. Rubio A; Garland GD; Sfakianos A; Harvey RF; Willis AE Semin Cancer Biol; 2022 Nov; 86(Pt 3):151-165. PubMed ID: 35487398 [TBL] [Abstract][Full Text] [Related]
4. Eukaryotic translation initiation factors as promising targets in cancer therapy. Hao P; Yu J; Ward R; Liu Y; Hao Q; An S; Xu T Cell Commun Signal; 2020 Nov; 18(1):175. PubMed ID: 33148274 [TBL] [Abstract][Full Text] [Related]
5. Eukaryotic translation initiation factors and cancer. Ali MU; Ur Rahman MS; Jia Z; Jiang C Tumour Biol; 2017 Jun; 39(6):1010428317709805. PubMed ID: 28653885 [TBL] [Abstract][Full Text] [Related]
6. Established and Emerging Regulatory Roles of Eukaryotic Translation Initiation Factor 5B (eIF5B). Chukka PAR; Wetmore SD; Thakor N Front Genet; 2021; 12():737433. PubMed ID: 34512736 [TBL] [Abstract][Full Text] [Related]
7. Eukaryotic translation initiation factors in cancer development and progression. Spilka R; Ernst C; Mehta AK; Haybaeck J Cancer Lett; 2013 Oct; 340(1):9-21. PubMed ID: 23830805 [TBL] [Abstract][Full Text] [Related]
8. Structure and functions of the translation initiation factor eIF4E and its role in cancer development and treatment. Piserà A; Campo A; Campo S J Genet Genomics; 2018 Jan; 45(1):13-24. PubMed ID: 29396141 [TBL] [Abstract][Full Text] [Related]
10. Translational control of eukaryotic gene expression. Van Der Kelen K; Beyaert R; Inzé D; De Veylder L Crit Rev Biochem Mol Biol; 2009; 44(4):143-68. PubMed ID: 19604130 [TBL] [Abstract][Full Text] [Related]
11. Protein synthesis and its control in neuronal cells with a focus on vanishing white matter disease. Pavitt GD; Proud CG Biochem Soc Trans; 2009 Dec; 37(Pt 6):1298-310. PubMed ID: 19909266 [TBL] [Abstract][Full Text] [Related]
12. Impact of Eukaryotic Translation Initiation Factors on Breast Cancer: Still Much to Investigate. Chen Q; Yang B; Nass N; Schatz C; Haybaeck J Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32708122 [TBL] [Abstract][Full Text] [Related]
13. Non-canonical translation in cancer: significance and therapeutic potential of non-canonical ORFs, m Deng X; Yu YV; Jin YN Cell Death Discov; 2024 Sep; 10(1):412. PubMed ID: 39333489 [TBL] [Abstract][Full Text] [Related]
14. Translation Initiation Factors: Reprogramming Protein Synthesis in Cancer. Chu J; Cargnello M; Topisirovic I; Pelletier J Trends Cell Biol; 2016 Dec; 26(12):918-933. PubMed ID: 27426745 [TBL] [Abstract][Full Text] [Related]
15. Initiation factor eIF3 and regulation of mRNA translation, cell growth, and cancer. Dong Z; Zhang JT Crit Rev Oncol Hematol; 2006 Sep; 59(3):169-80. PubMed ID: 16829125 [TBL] [Abstract][Full Text] [Related]
16. [Research progress in the mechanism of translation initiation of eukaryotic mRNAs]. Zheng CX; Ma XF; Zhang YH; Li HJ; Zhang GF Yi Chuan; 2018 Aug; 40(8):607-619. PubMed ID: 30117417 [TBL] [Abstract][Full Text] [Related]
17. Identification of eukaryotic translation initiation factors and the temperature-dependent nature of Shopan J; Liu C; Hu Z; Zhang M; Yang J 3 Biotech; 2020 Feb; 10(2):75. PubMed ID: 32051808 [TBL] [Abstract][Full Text] [Related]
18. Translational control gone awry: a new mechanism of tumorigenesis and novel targets of cancer treatments. Yin JY; Dong Z; Liu ZQ; Zhang JT Biosci Rep; 2011 Feb; 31(1):1-15. PubMed ID: 20964625 [TBL] [Abstract][Full Text] [Related]
19. Eukaryotic initiation factor 4F: a vulnerability of tumor cells. Lee T; Pelletier J Future Med Chem; 2012 Jan; 4(1):19-31. PubMed ID: 22168162 [TBL] [Abstract][Full Text] [Related]
20. Spatial and temporal translational control of germ cell mRNAs mediated by the eIF4E isoform IFE-1. Friday AJ; Henderson MA; Morrison JK; Hoffman JL; Keiper BD J Cell Sci; 2015 Dec; 128(24):4487-98. PubMed ID: 26542024 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]